spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online March 14, 2005
Journal of Experimental Biology 208, 1063-1077 (2005)
Published by The Company of Biologists 2005
doi: 10.1242/jeb.01491
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, W. S.
Right arrow Articles by Hoffmann, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, W. S.
Right arrow Articles by Hoffmann, E. K.

Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium

W. S. Marshall1,*, C. G. Ossum2 and E. K. Hoffmann2

1 Department of Biology, St Francis Xavier University, PO Box 5000 Antigonish, Nova Scotia, Canada B2G 2W5
2 Department of Biochemistry, August Krogh Institute, University of Copenhagen, 13 Universitetsparken, Copenhagen DK-2100, Denmark



View larger version (16K):

[in a new window]
 
Fig. 1. Effect of hypotonic shock in isolated opercular epithelia mounted in symmetrical saline. (A) Example trace of time course of hypotonic shock on Vt, a 1 h duration period in hypotonic conditions and overshoot after restoration of isotonic conditions. (B) The size of the overshoot is a function of the period of hypotonic exposure; short periods yield no overshoot, longer periods yield larger overshoot in current, indicative of regulatory volume decrease during long hypotonic exposure.

 


View larger version (15K):

[in a new window]
 
Fig. 2. The cycloxygenase inhibitor indomethacin (0.1 mmol l-1) had no detectable effect on the hypotonic response (HYPO) and no effect on the current rebound when isotonic conditions were restored (ISO).

 


View larger version (16K):

[in a new window]
 
Fig. 3. The protein kinase C inhibitor chelerythrine (Chel) significantly inhibited membrane current compared to vehicle (Veh) treatment (**P<0.01, paired t-test) and significantly reduced the recovery of current after isotonic (ISO) solutions were restored (*P<0.05, paired t-test).

 


View larger version (28K):

[in a new window]
 
Fig. 4. The p38 MAPK inhibitor SB203580 had no effect on current (A) compared to the vehicle-treated membranes (Drug/Veh), but SB203580 significantly enhanced the inhibition of current by hypotonic shock (HYPO) and significantly reduced the recovery of current after restoration of isotonic conditions (ISO; *P<0.05, paired t-test). The transepithelial resistance (B) change mirrors the current changes, with SB203580 increasing the resistance rise compared to vehicle (*P<0.05, paired t-test) seen with hypotonic shock.

 


View larger version (33K):

[in a new window]
 
Fig. 5. Immunoblot of protein form opercular epithelia treated for different times with isotonic solution (control), hypotonic saline (Hypo) and hypertonic saline (Hyper). (A) Upper panel: p38 MAPK (38-40 kDa) was detected by antibody to any form of the protein. Lower panel: p38 MAPK detected by the antibody specific to the phosphorylated form of the protein. (B) Bar charts of quantitative scans averaged over three immunoblots where p38 MAPK phosphorylation was enhanced significantly (*P<0.05, paired t-test compared to isotonic control level at the respective time, N=3) by hypotonic shock at 5 min, by hypertonic shock at 30 min and by both hypertonic and hypotonic shock in a second phase response at 60 min.

 


View larger version (19K):

[in a new window]
 
Fig. 6. The p38 MAPK is present in opercular epithelium and gill epithelial tissue in fully acclimated freshwater and seawater animals. Scans averaged over three immunoblots (top) indicate a lower level of expression of p38 MAPK (bottom) in seawater relative to freshwater levels in both gill and opercular epithelium (*P<0.05, t-test, N=3).

 


View larger version (14K):

[in a new window]
 
Fig. 7. The protein phosphatase inhibitor okadaic acid significantly increased membrane current initially (*P<0.05, paired t-test), had a marginal potentiating effect on the magnitude of the hypotonic inhibition of current (*P<0.05, paired t-test) and entirely blocked the recovery of current (**P<0.02, paired t-test) after restoration of isosmotic solutions.

 


View larger version (15K):

[in a new window]
 
Fig. 8. The protein tyrosine kinase inhibitor genistein (Gen; 0.1 mmol l-1) if added to membranes with high levels of current (salt water) caused a significant inhibition (**P<0.01, unpaired t-test) compared to vehicle controls. However, if the current was inhibited first by clonidine (Clon; {alpha}2 adrenergic agonist, 1.0 µmol l-1), genistein instead increased the current to an intermediate level (*P<0.05). The inactive analogue daidzein (0.1 mmol l-1) has no inhibitory effect (Marshall et al., 2000Go).

 


View larger version (25K):

[in a new window]
 
Fig. 9. (A) Immunoblots of phosphorylated JNK (phospho-JNK) were similar to those for p38 MAPK (Fig. 5) but were normalized to the control values to remove a tendency for pJNK to increase with time. (B) There was a significant rise in pJNK in both hyper- (bottom) and hypotonic (top) shock at 5 min (*P<0.05, t-test, N=3) and with hypertonic shock at 30 min (*P<0.05), compared to the isotonic controls at the same time.

 


View larger version (30K):

[in a new window]
 
Fig. 10. Immunoblot of the stress-associated proteins OSR1 (A) and SPAK (B), comparing expression in freshwater (FW)- and seawater (SW)-acclimated animals. Quantitative western analysis revealed significantly higher level of OSR1 and SPAK expression in FW- as compared to SW-acclimated animals for the gill and opercular epithelium (oe; N=3, *P<0.05) with the difference in OSR1 expression being more marked than that for SPAK.

 


View larger version (52K):

[in a new window]
 
Fig. 11. Immunocytochemistry for NKCC (T4 mouse anti-hNKCC antibody with goat anti-mouse Oregon Green 488) and for SPAK (rabbit anti-SPAK polyclonal with goat anti-rabbit Alexa Fluor 594) visualized by confocal microscopy. (A) Anti-NKCC alone (green) (B) Anti-SPAK alone (red) (C) Same field as A and B but with both channels activated (red/green); exact colocalization is yellow. NKCC and SPAK appear in the same mitochondria-rich cells, not in the apical membrane but lower in the cell (here at the plane of the nuclei) and, in most areas are exactly colocalized (yellow in C). (D) A line scan of fluorescence intensity (arbitrary units) versus distance in µm across a cell (indicated by the arrow in C) shows good correspondence in the colocalization of SPAK (red line) and NKCC (green line) in the cytosol (peaks) and not in the nucleus (central region). (E-H) As A-D except that the primary antibody for the kinase was rabbit anti-OSR1 polyclonal, not SPAK. Bars, 20 µm.

 


View larger version (38K):

[in a new window]
 
Fig. 12. Immunocytochemistry for phosphorylated focal adhesion kinase (pFAK) (primary: rabbit anti-phosphorylated human FAK; secondary: goat anti-rabbit Oregon Green 488) and for NKCC (primary: T4 mouse anti-hNKCC; secondary: goat anti-mouse Alexa Fluor 594). (A) pFAK immunofluorescence was present in all mitochondria-rich cells (green). (B) NKCC immunofluorescence (red) had a similar distribution to pFAK. (C) There was a high degree of colocalization of NKCC and phosphorylated pFAK (yellow). (D) Genistein pretreatment (100 µmol l-1, for 1 h) to inhibit tyrosine kinase before addition of the primary anti-pFAK antibody eliminated pFAK immunofluorescence. Bar, 20 µm.

 





© The Company of Biologists Ltd 2005